Inogen Inc
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated | ||||
|---|---|---|---|---|
| Incorporated · by Reference | ||||
| Exhibit · by Reference · From Exhibit · Date | ||||
| Number | Description | From Form | Number | Filed |
| 2.1#* · Asset Purchase Agreement, dated September 29, 2026, by and between the Company and Rotech Healthcare Inc. · Filed herewith | ||||
| 10.1+ | Employment and Severance Agreement by and between the Company and Andrew Reding, effective as of July 6, 2026 | 8-K | 10.1 | 07/01/26 |
| 10.2+ | Form of Inducement Award Restricted Stock Unit Agreement - Time Based | S-8 | 99.1 | 07/24/26 |
| 10.3+ | Amendment to Employment and Severance Agreement by and between the Company and Andy Reding, effective as of October 30, 2026 | 8-K | 10.1 | 11/05/26 |
| 31.1 | Certification Pursuant to Exchange Act Rules 13a - 14(a) and 15d - 14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer | Filed herewith | ||
| 31.2 | Certification Pursuant to Exchange Act Rules 13a - 14(a) and 15d - 14(a), as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer | Filed herewith | ||
| 32.1(1) | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer | Filed herewith | ||
| 32.2(1) | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer | Filed herewith | ||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | |||
| 104 | The cover page of this Quarterly Report on Form 10-Q, formatted in inline XBRL. | |||
- Indicates a management contract or compensatory plan.
Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K, and certain identified information has been omitted pursuant to Item 601(b)(2)(ii) of Regulation S-K because it is both not material and is the type of information that the Company treats as private or confidential. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit, and an unredacted copy of the agreement, to the SEC upon request.
- Certain personally identifiable information, marked by brackets and asterisks, has been omitted from this exhibit pursuant to Item 601(a)(6) of Regulation S-K.
(1) The Certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Inogen, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.